AVENUE THERAPEUTICS, INC. (ATXI)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, AVENUE THERAPEUTICS, INC. reported revenue of $1.40M. The company ran a net loss, with a net margin of -207.2%. It held $2.93M in total assets against $1.10M in total liabilities.
Key ratios (FY2025)
-219.6%
Operating margin
-207.2%
Net margin
-158.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40M | $0 | — | — | — | — | — | — | — | — |
| Operating Income | -$3.08M | -$11.28M | -$14.54M | -$8.04M | -$3.74M | -$5.21M | -$26.27M | -$21.82M | -$11.42M | -$2.38M |
| Net Income | -$2.91M | -$11.65M | — | -$3.55M | -$3.73M | -$5.15M | -$25.91M | -$21.55M | -$12.26M | -$3.18M |
| EPS (Diluted) | $-0.93 | $-15.79 | $-73.48 | $-1.63 | $-0.22 | $-0.31 | — | — | — | — |
| Total Assets | $2.93M | $2.67M | $1.85M | $6.84M | $3.96M | $3.25M | $8.91M | $4.53M | $22.17M | $197.0K |
| Total Liabilities | $1.10M | $816.0K | $1.20M | $3.58M | $509.0K | $886.0K | $2.12M | $5.16M | $2.79M | $8.45M |
| Shareholders' Equity | $1.83M | $2.80M | $1.58M | $3.90M | $3.45M | $2.36M | $6.80M | -$631.0K | $19.38M | -$8.25M |
| Cash & Equivalents | $2.85M | $2.59M | $1.78M | $6.71M | $3.76M | $3.13M | $8.74M | $2.67M | $11.78M | $197.0K |
| Operating Cash Flow | -$1.83M | -$9.03M | -$9.45M | -$7.60M | -$3.75M | -$4.61M | -$26.26M | -$18.22M | -$6.80M | -$1.63M |
| Shares Outstanding | 3.18M | 2.11M | 341.3K | 4.77M | 1.41M | 16.75M | 16.68M | 10.67M | 10.27M | 3.26M |